Association of choroid plexus volume with white matter microstructure, glymphatic function, and peripheral systemic inflammation in Alzheimer’s disease
Authors:
- Chaoqun WangCWChaoqun Wang
- For The Alzheimer’s Disease Neuroimaging InitiativeFIFor The Alzheimer’s Disease Neuroimaging Initiative
- Weihong SongWSWeihong Song
- Yili WuYWYili Wu
Top Cited Papers
Open Access
- 11 July 2025
- journal article
- research article
- Published by Springer Nature in Translational Psychiatry
- Vol. 15 (1) , 1-9
Abstract
There has been growing attention to the role of choroid plexus (CP) in neurodegenerative diseases. However, its relationship with various pathophysiological changes in Alzheimer’s Disease (AD) remains unclear. The purpose of this study is to investigate the relationship between CP volume (CPV) and white matter microstructure, cognitive function, glymphatic function, and peripheral systemic inflammation in AD. A total of 1351 participants with cognitive impairment who had available 3 T MRI scans were included from ADNI. CPV was automatically segmented using Gaussian Mixture Model (GMM). The Mini-Mental State Examination (MMSE) was employed to assess cognitive function. PSMD and DTI-ALPS based on DTI sequence were used to reflect white matter microstructure and glymphatic system. Peripheral systemic inflammation was represented by the neutrophil-lymphocyte ratio (NLR). Group comparisons and correlations were adjusted for age, sex, education and APOE4 carrier status. Participants with AD exhibited larger CPV (p < 0.001), higher PSMD (p < 0.001) and NLR (p = 0.035), and lower DTI-ALPS (p < 0.001) compared to those with subjective cognitive decline (SCD). CP enlargement was independently associated with higher PSMD (β = 0.223, p < 0.001) and worse cognitive function both cross-sectionally (β = −0.212, p < 0.001) and longitudinally (β = −0.214, p < 0.001). Furthermore, PSMD partially mediates the impact of CP enlargement on the severity and progression of cognitive function. Partial correlation analysis revealed that CP enlargement was associated with higher NLR (r = 0.101, p = 0.001) and lower DTI-ALPS (r = −0.241, p < 0.001). These findings suggest that CPV may reflect underlying pathophysiological processes in AD and serve as a biomarker for white matter damage and cognitive impairment progression.Keywords
Funding Information
- National Natural Science Foundation of China (82150710557)
This publication has 71 references indexed in Scilit:
- Magnetic ResonanceImages Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction inAlzheimer DiseaseAnnals of Neurology, 2022
- White matter integrity and structural brain network topology in cerebral small vessel disease: The Hamburg city health studyHuman Brain Mapping, 2020
- Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and diseaseActa Neuropathologica, 2018
- Evaluation of glymphatic system activity with the diffusion MR technique: diffusion tensor image analysis along the perivascular space (DTI-ALPS) in Alzheimer’s disease casesJapanese Journal of Radiology, 2017
- A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion HistogramsAnnals of Neurology, 2016
- Choroid plexus implants rescue Alzheimer’s disease-like pathologies by modulating amyloid-β degradationCellular and Molecular Life Sciences, 2013
- Contemplating Alzheimer’s Disease and the Contribution of White Matter HyperintensitiesCurrent Neurology and Neuroscience Reports, 2013
- Regional White Matter Hyperintensity Volume, Not Hippocampal Atrophy, Predicts Incident Alzheimer Disease in the CommunityArchives of Neurology, 2012
- Morphological alterations of the choroid plexus in late-onset Alzheimer’s diseaseActa Neuropathologica, 2000
- “Mini-mental state”Journal of Psychiatric Research, 1975